Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

“Teal” has become a vexed term for those of us who follow Australia’s independents movement. I advocate for a narrow use of the term, referring to climate-focused indies challenging Liberals ...

On February 4, Merck released financial results for Q4 2024, which, as in previous quarters, once again beat analysts' expectations. This was driven by a strong performance by its oncology ...

Mer­ck said its “once-in-a-life­time” drug Keytru­da could be sub­ject to price re­duc­tions un­der the In­fla­tion Re­duc­tion Act, which would lead to a … ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

All color used on the web — defined in CSS or used in graphics and video — should match the RGB or HEX color values defined by the UH Style Guidelines for color. Converting PMS or CMYK color values to ...

Ivonescimab, the new drug, was found in a trial conducted in China to have bested Keytruda, the blockbuster medication developed by Merck that has raked in more than $130 billion in sales for the ...

Merck (NYSE:MRK) said it expects its top-selling drug, Keytruda, to be selected by the U.S. government for price setting negotiations next year under the Inflation Reduction Act. In a filing with ...

The wave of teal independents at the 2022 federal election rocked the political establishment and prompted declarations that the two-party system was splintering. Backed by nearly $10 million from ...

The development comes as discussions heat up about the pivotal role independents could play in the next parliament. Ms Steggall and other members of the crossbench, including Bob Katter and Kate ...